Oncological healthcare providers' perspectives on appropriate melanoma survivorship care: a qualitative focus group study
- PMID: 36973713
- PMCID: PMC10042579
- DOI: 10.1186/s12885-023-10759-9
Oncological healthcare providers' perspectives on appropriate melanoma survivorship care: a qualitative focus group study
Abstract
Background: The increasing group of melanoma survivors reports multiple unmet needs regarding survivorship care (SSC). To optimise melanoma SSC, it is crucial to take into account the perspectives of oncological healthcare providers (HCPs) in addition to those of patients. The aim of this study is to gain an in-depth understanding of HCPs' perspectives on appropriate melanoma SSC.
Methods: Four online focus groups were conducted with mixed samples of oncological HCPs (dermatologists, surgeons, oncologists, oncological nurse practitioners, support counsellors and general practitioners) (total n = 23). A topic guide was used to structure the discussions, focusing on perspectives on both SSC and survivorship care plans (SCPs). All focus groups were recorded, transcribed verbatim, and subjected to an elaborate thematic content analysis.
Results: Regarding SSC, HCPs considered the current offer minimal and stressed the need for broader personalised SSC from diagnosis onwards. Although hardly anyone was familiar with SCPs, they perceived various potential benefits of SCPs, such as an increase in the patients' self-management and providing HCPs with an up-to-date overview of the patient's situation. Perceived preconditions for successful implementation included adequate personalisation, integration in the electronic health record and ensuring adequate funding to activate and provide timely updates.
Conclusions: According to HCPs there is considerable room for improvement in terms of melanoma SSC. SCPs can assist in offering personalised and broader i.e., including psychosocial SSC. Aside from personalisation, efforts should be focused on SCPs' integration in clinical practice, and their long-term maintenance.
Keywords: Melanoma; Qualitative research; Survivorship care; Survivorship care plan.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Exploring Motives Behind Ideal Melanoma Survivorship Care Plans With Multiple Stakeholders: A Cocreation Study.JMIR Cancer. 2025 Jan 2;11:e55746. doi: 10.2196/55746. JMIR Cancer. 2025. PMID: 39746197 Free PMC article.
-
Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma.Br J Dermatol. 2022 Sep;187(3):381-391. doi: 10.1111/bjd.21670. Epub 2022 Jun 14. Br J Dermatol. 2022. PMID: 35596713 Free PMC article.
-
Thai oncology nurses' perspectives toward survivorship care plan components and implementation for colorectal cancer survivors.Support Care Cancer. 2022 May;30(5):4089-4098. doi: 10.1007/s00520-021-06766-w. Epub 2022 Jan 23. Support Care Cancer. 2022. PMID: 35066665
-
Role of the nurse in the design, delivery, monitoring and coordination of cancer survivorship care plans: An integrative review.J Adv Nurs. 2022 Jan;78(1):48-62. doi: 10.1111/jan.14962. Epub 2021 Jul 7. J Adv Nurs. 2022. PMID: 34235775 Review.
-
Use and impact of breast cancer survivorship care plans: a systematic review.Breast Cancer. 2021 Nov;28(6):1292-1317. doi: 10.1007/s12282-021-01267-4. Epub 2021 Jun 19. Breast Cancer. 2021. PMID: 34146242
Cited by
-
Exploring Motives Behind Ideal Melanoma Survivorship Care Plans With Multiple Stakeholders: A Cocreation Study.JMIR Cancer. 2025 Jan 2;11:e55746. doi: 10.2196/55746. JMIR Cancer. 2025. PMID: 39746197 Free PMC article.
-
Getting back on track after treatment of cancer: A qualitative interview study of cancer survivors' experiences.PLoS One. 2025 Jan 9;20(1):e0313984. doi: 10.1371/journal.pone.0313984. eCollection 2025. PLoS One. 2025. PMID: 39787181 Free PMC article.
-
"There is a life before and after cancer": experiences of resuming life and unmet care needs in stage I and II melanoma survivors.Arch Dermatol Res. 2024 Sep 26;316(9):645. doi: 10.1007/s00403-024-03376-4. Arch Dermatol Res. 2024. PMID: 39325191 Free PMC article.
References
-
- Leeneman B, Schreuder K, Uyl-de Groot CA, van Akkooi ACJ, Haanen J, Wakkee M, et al. Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study. Eur J Cancer. 2021;154:111–119. doi: 10.1016/j.ejca.2021.06.007. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical